Marijuana rescheduling means Tilray is finally eying the US cannabis market - Stock Watch Index

Marijuana rescheduling means Tilray is finally eying the US cannabis market

May 7, 2026

Tilray CEO Irwin Simon sees a future where cannabis is treated like other medicine: prescribed by doctors and tailored to patients’ needs.

Search

RECENT PRESS RELEASES

May 7: Cannabis Corruption | Tablet Magazine

SWI Editorial Staff2026-05-07T13:34:03-07:00May 7, 2026|

This hedge-fund legend just warned investors not to chase stocks higher. Why he is investing in AI anyway.

SWI Editorial Staff2026-05-07T13:32:00-07:00May 7, 2026|

IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings

SWI Editorial Staff2026-05-07T13:30:00-07:00May 7, 2026|

IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings

SWI Editorial Staff2026-05-07T13:30:00-07:00May 7, 2026|

Audit finds Kentucky medical cannabis program was ‘fair’ in licensing

SWI Editorial Staff2026-05-07T13:29:00-07:00May 7, 2026|

X ranks lowest on social media safety ranking for LGBTQ users

SWI Editorial Staff2026-05-07T13:28:26-07:00May 7, 2026|

Related Post